Viral proteins play a central role in the life cycle of viruses and their interactions with host cells. These proteins are encoded by viral genomes and serve various functions essential for viral replication, evasion of host immune responses, and assembly of new virus particles. Key viral proteins include structural proteins that form the viral capsid or envelope, facilitating virus entry into host cells. Enzymatic proteins, such as polymerases and proteases, are critical for viral genome replication and protein processing. Non-structural proteins often modulate host cell functions, subverting cellular machinery to support viral replication. Viral proteins also contribute to immune evasion by interfering with host antiviral responses. For example, some viruses encode proteins that inhibit the host's ability to recognize and respond to viral infections. Understanding viral proteins is pivotal for developing antiviral therapies and vaccines. Targeting specific viral proteins can disrupt the viral life cycle or elicit immune responses that provide protection. Ongoing research continues to unveil the intricacies of viral protein functions, offering insights into new strategies for combating viral infections.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States